GENE ONLINE|News &
Opinion
Blog

Cardiovascular Disease
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Will Vascepa Receive a FDA Approval as a New Year Gift?
2019-12-02
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
LATEST
Recounting 25 Years of Genetic and Human Diversity Discovery With deCODE Founder Kari Stefansson
2022-05-26
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia
2022-05-25
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Lonza Signs CDMO Deal to Break Into Israeli Market
2022-05-25
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Travecta Therapeutics Announces In-Person Presentation at 2022 BIO International Convention
2022-05-24
Global Race to Track and Contain Monkeypox Outbreak
2022-05-24
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!